标题
Botulinum Toxin in the Treatment of Headache
作者
关键词
-
出版物
Toxins
Volume 12, Issue 12, Pages 803
出版商
MDPI AG
发表日期
2020-12-18
DOI
10.3390/toxins12120803
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Botulinum toxin in the management of temporomandibular disorders: a systematic review
- (2020) S. Thambar et al. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
- A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine
- (2020) Paul K. Winner et al. HEADACHE
- Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice
- (2020) Olivia Begasse de Dhaem et al. HEADACHE
- Dual Therapy With Anti‐CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?
- (2020) Lanfranco Pellesi et al. HEADACHE
- Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review
- (2020) Rami Burstein et al. HEADACHE
- Access to Migraine Treatments in Ontario, Canada: A Review of the Ontario Drug Benefit Program
- (2020) Susan Cape HEADACHE
- Efficacy of Botulinum Toxin in Tension-Type Headaches: A Systematic Review of the Literature
- (2019) Brin Freund et al. Pain Practice
- Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study
- (2019) William B. Young et al. JOURNAL OF HEADACHE AND PAIN
- A systematic review of botulinum toxin in the management of patients with temporomandibular disorders and bruxism
- (2019) Jalpesh Patel et al. BRITISH DENTAL JOURNAL
- Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine
- (2019) Messoud Ashina et al. CEPHALALGIA
- Prognosis Following Discontinuation of OnabotulinumA Therapy in “Super‐responding” Chronic Migraine Patients
- (2019) Jason Ching et al. HEADACHE
- FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
- (2019) John F. Rothrock et al. HEADACHE
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Migraine is first cause of disability in under 50s: will health politicians now take notice?
- (2018) Timothy J. Steiner et al. JOURNAL OF HEADACHE AND PAIN
- CGRP as the target of new migraine therapies — successful translation from bench to clinic
- (2018) Lars Edvinsson et al. Nature Reviews Neurology
- Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine
- (2018) Ioana Ion et al. Toxins
- The Expanding Therapeutic Utility of Botulinum Neurotoxins
- (2018) Elena Fonfria et al. Toxins
- Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity
- (2018) Elena Fonfria et al. Toxins
- Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
- (2018) Lars Bendtsen et al. JOURNAL OF HEADACHE AND PAIN
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes
- (2017) Andrew M. Blumenfeld et al. HEADACHE
- Fremanezumab - a humanized monoclonal anti-CGRP antibody — inhibits thinly myelinated (Aδ) but not unmyelinated (C) meningeal nociceptors
- (2017) Agustin Melo-Carrillo et al. JOURNAL OF NEUROSCIENCE
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Evidencia y experiencia del uso de onabotulinumtoxinA en neuralgia del trigémino y cefaleas primarias distintas de la migraña crónica
- (2017) S. Santos-Lasaosa et al. NEUROLOGIA
- Pathophysiology of Migraine: A Disorder of Sensory Processing
- (2017) Peter J. Goadsby et al. PHYSIOLOGICAL REVIEWS
- Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’ responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
- (2016) XiChun Zhang et al. CEPHALALGIA
- Interventional Treatment for Post-traumatic Headache
- (2016) Francis X. Conidi Current Pain and Headache Reports
- Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache
- (2016) David M. Simpson et al. NEUROLOGY
- A Research Synthesis of Therapeutic Interventions for Whiplash-Associated Disorder (WAD): Part 5 – Surgical and Injection-Based Interventions for Chronic WAD
- (2016) Robert W Teasell et al. Pain Research & Management
- Botulinum toxin drugs: brief history and outlook
- (2015) D. Dressler JOURNAL OF NEURAL TRANSMISSION
- Botulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents
- (2015) Roshni Ramachandran et al. NEUROBIOLOGY OF DISEASE
- OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine
- (2015) Eva Cernuda-Morollón et al. PAIN
- Current Status and Future Directions of Botulinum Neurotoxins for Targeting Pain Processing
- (2015) Sabine Pellett et al. Toxins
- Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?
- (2014) Eva Cernuda-Morollón et al. CEPHALALGIA
- Innervation of Rat and Human Dura Mater and Pericranial Tissues in the Parieto-Temporal Region by Meningeal Afferents
- (2014) Markus Schueler et al. HEADACHE
- Headache Direction and Aura Predict Migraine Responsiveness to Rimabotulinumtoxin B
- (2012) Patrick M. Grogan et al. HEADACHE
- Onabotulinum toxin A treatment of cervicogenic headache: A randomised, double-blind, placebo-controlled crossover study
- (2011) Mattias Linde et al. CEPHALALGIA
- Activation of central trigeminovascular neurons by cortical spreading depression
- (2010) XiChun Zhang et al. ANNALS OF NEUROLOGY
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
- (2010) SK Aurora et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
- On muscle spindles, dystonia and botulinum toxin
- (2010) R. L. Rosales et al. EUROPEAN JOURNAL OF NEUROLOGY
- Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program
- (2010) Andrew Blumenfeld et al. HEADACHE
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
- (2010) David W. Dodick et al. HEADACHE
- A Double-Blind Comparison of OnabotulinumtoxinA (BOTOX®) and Topiramate (TOPAMAX®) for the Prophylactic Treatment of Chronic Migraine: A Pilot Study
- (2009) Ninan T. Mathew et al. HEADACHE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now